Zydus Lifesciences Limited — Others, 06-02-2025: Copy of Newspaper Publication

Zydus Lifesciences Limited has announced a board meeting to present the financial results for the quarter and nine months ended December 31, 2024. The results have received Auditor's Limited Review Reports and are accessible on the company website and major exchanges. This update reflects ongoing operational transparency and financial health, which may bolster investor confidence. Stakeholders might view this as a strong indicator of management's commitment to accountability and timely disclosures, presenting a positive outlook for the company amidst the evolving market landscape.